This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

NICE - indication for fresh frozen plasma (FFP)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Fresh frozen plasma

Thresholds and targets

Fresh frozen plasma transfusion for patients should only be considered with clinically significant bleeding but without major haemorrhage if they have abnormal coagulation test results (for example, prothrombin time ratio or activated partial thromboplastin time ratio above 1.5).

Do not offer fresh frozen plasma transfusions to correct abnormal coagulation in patients who:

  • are not bleeding (unless they are having invasive procedures or surgery with a risk of clinically significant bleeding)
  • need reversal of a vitamin K antagonist

Consider prophylactic fresh frozen plasma transfusions for patients with abnormal coagulation who are having invasive procedures or surgery with a risk of clinically significant bleeding.

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.